US2015216807A1PendingUtilityA1
Solubilized coq-10
Est. expirySep 29, 2023(expired)· nominal 20-yr term from priority
Inventors:Michael Fantuzzi
A61K 31/045A61K 47/06A61K 9/4875A23L 33/16A61K 47/44A61K 31/122A61K 9/4833A61K 9/4891A61K 9/4825A61K 9/4858A61K 47/22A61K 31/12A61P 3/02A61K 31/355
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 in formulations, such as soft gel capsules.
Claims
exact text as granted — not AI-modified1 . A composition comprising:
coenzyme Q-10 or an analog thereof; a sufficient quantity of a monoterpene suitable to solubilize said coenzyme Q-10; and an acceptable carrier.
2 . The composition of claim 1 , wherein said coenzyme Q-10 or an analog thereof is selected from the group consisting of coenzyme Q-10, reduced coenzyme Q-10 and semi-reduced coenzyme Q-10.
3 . The composition of claim 1 , wherein said monoterpene is limonene or a derivative thereof.
4 . The composition of claim 3 , wherein said limonene derivatives are selected from the group consisting of perillyl alcohol, perillic acid, cis-dihydroperillic acid, trans-dihydroperillic acid, methyl esters of perillic acid, methyl esters of dihydroperillic acid, limonene-2-diol, uroterpenol, and combinations thereof.
5 . The composition of claim 1 , wherein said composition is in the form of a solution, an elixir, a suspension, or a caplet.
6 . The composition of claim 5 , wherein said caplet is a soft gelatin tablet.
7 . The composition of claim 6 , wherein said soft gelatin tablet further comprises rice bran oil or beeswax.
8 . The composition of claim 1 , wherein said coenzyme Q-10 or analog thereof is solubilized in said monoterpene in an amount of at least about 0.1% by weight to about 45% by weight at room temperature.
9 . The composition of claim 1 , wherein said coenzyme Q-10 or analog thereof is solubilized in said monoterpene in an amount of least about 5% to about 40% by weight at room temperature.
10 . The composition of claim 1 , further comprising vitamin E.
11 . The composition of claim 1 , further comprising a seed oil.
12 . The composition of claim 1 , further comprising a fish oil
13 . The composition of claim 1 , further comprising an antioxidant.
14 . A soft gelatin capsule, comprising
at least 5% by weight of coenzyme Q-10 or an analog thereof solubilized in a monoterpene.
15 . The soft gelatin capsule of claim 14 , wherein said coenzyme Q-10 or analog thereof is selected from the group consisting of coenzyme Q-10, reduced coenzyme Q-10 and semi-reduced coenzyme Q-10.
16 . The soft gelatin capsule of claim 14 , wherein said monoterpene is limonene or a derivative thereof.
17 . The soft gelatin capsule of claim 16 , wherein said limonene derivative is selected from the group consisting of perillyl alcohol, perillic acid, cis-dihydroperillic acid, trans-dihydroperillic acid, methyl esters of perillic acid, methyl esters of dihydroperillic acid, limonene-2-diol, uroterpenol, and combinations thereof.
18 . The soft gelatin capsule of claim 14 , wherein said coenzyme Q-10 is solubilized in said monoterpene in an amount of about 10 percent to about 40 percent by weight.
19 . The composition of claim 14 , wherein said soft gelatin tablet further comprises rice bran oil or beeswax.
20 . The composition of claim 14 , wherein said soft gelatin tablet further comprises an antioxidant.
21 - 24 . (canceled)Join the waitlist — get patent alerts
Track US2015216807A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.